iRhythm Holdings Inc IRTC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
-
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
-
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
-
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
-
Here's how to position your portfolio for the next AI wave, according to Morgan Stanley
-
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
-
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
-
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
Trading Information
- Previous Close Price
- $119.64
- Day Range
- $117.67–122.50
- 52-Week Range
- $100.70–212.00
- Bid/Ask
- $91.99 / $150.00
- Shares Outstanding
- 32.96M
- Market Cap
- $4.00B
- Volume/Avg
- 456,765 / 563,964
Key Statistics
- Price/Earnings (Normalized)
- 250.44
- Price/Sales
- 4.77
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 2,400
- Website
- https://www.irhythmtech.com
Valuation
|
Metric
|
IRTC
|
|---|---|
Price/Earnings (Normalized) | 250.44 |
Price/Book Value | 21.47 |
Price/Sales | 4.77 |
Price/Cash Flow | 19.86 |
Price/Earnings
IRTC
Financial Strength
|
Metric
|
IRTC
|
|---|---|
Quick Ratio | 3.44 |
Current Ratio | 3.85 |
Interest Coverage | −1.58 |
Quick Ratio
IRTC
Profitability
|
Metric
|
IRTC
|
|---|---|
Return on Assets (Normalized) | 1.55% |
Return on Equity (Normalized) | 10.83% |
Return on Invested Capital (Normalized) | 1.08% |
Return on Assets
IRTC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|k%kLGrT | LOCK|jm&yH | $179B | |||
| Medtronic PLC
MDT
| LOCK|!&L@&! | LOCK|RQ?& | $122B | |||
| Stryker Corp
SYK
| LOCK|ZN?@?!^! | LOCK|G>> | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|C^N<BZ | LOCK|X<^Q | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%xRy%Hk% | LOCK|Sd$M | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<r<pTJ | LOCK|>d? | $32B | |||
| DexCom Inc
DXCM
| LOCK|&ldcZGz | LOCK|&^^% | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Dh@ | LOCK|!n | $26B | |||
| Steris PLC
STE
| LOCK|pQr%$v | LOCK|?v^l | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|c#V?Fh& | LOCK|zP | $19B |
United States